IMVT Immunovant Therapeutics: Accounting Value per Share

Graphic logo of Immunovant, Inc. (IMVT)

The price action of Immunovant, Inc. (IMVT) reflects market expectations for the developer of targeted therapies for autoimmune pathologies, whose metrics reach 3.54. Share price growth is fueled by progress in antibody testing and support from Roivant. Synergy with biotech laboratories through partnerships is accelerating the launch of new drugs, while the environmental profile remains limited to basic biosafety and office energy efficiency.

Immunovant Inc (IMVT): Share Book Value from 07/04/2022 to 10/27/2026

immunovant.com - analytical breakdowns and key metrics (IMVT)

- price and consensus price forecast:
Stock Quotes Immunovant Corp|IMVT - Price Target Chart
- market capitalization data:
Market Valuation Immunovant, Inc.|IMVT - Aggregate Business Value
- book capitalization data:
Net Assets per Single Share Immunovant|IMVT - Net Asset Value|Market Capitalization to Book Value Ratio immunovant.com|IMVT - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Immunovant, Inc.|IMVT - Long-Term Debt to Capital|Short-Term Debt to Equity Immunovant|IMVT - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Immunovant, Inc.
Fundamental company valuation:Immunovant Corp - IMVT
Manufactured products of Immunovant

The bps_co metric serves as a fundamental tool for assessing the intrinsic value of a business through equity analysis. It is calculated as the difference between assets and liabilities, divided by the number of shares. For Immunovant, Inc. (IMVT), this metric reflects the efficiency of resource management under the control of Roivant Sciences. Competent planning of clinical phases minimizes risks, thereby stabilizing capital. By analyzing accounting data regarding the share price, an investor can discern the real trend of investment security.

Competitors of Immunovant, Inc. (IMVT)

ARGX - Accounting Value per Share|BioNTech Pharma (BNTX) - Net Assets per Single Share|ABVX - Accounting Value per Share|ADMA (admabiologics.com) - Book Price of a Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Kiniksa Pharmaceuticals, Ltd.|Grifols Group (GRFS) - Book Value per Share|Accounting Value of a Share Adaptive Biotechnologies Inc. (ADPT)|Book Value per Share CLDX (Celldex Therapeutics)|auriniapharma.com - Book Value per Share|Net Assets per Single Share BioCryst Pharmaceuticals (BCRX)|VERA: Accounting Value of a Share|DNTH (Dianthus Pharma) - Net Assets per Single Share|Pharvaris Pharma (PHVS) - Accounting Value per Share|ABCL (AbCellera Biologics Inc) - Book Value per Share|Book Value per Share tourmalinebio.com (TRML)|Precigen (PGEN) - Accounting Value per Share|Accounting Value of a Share Pharming Group NV (PHAR)|Book Value per Share NKTR|Upstream Pharma - Net Assets per Share|ZBIO: Net Assets per Single Share|IMNM: Accounting Value per Share|GOSS (Gossamer Bio) - Net Assets per Single Share|Accounting Value per Share KalVista Pharma|SEPN (Septerna Corp) - Accounting Value per Share|Book Value per Share PVLA|Net Assets per Single Share Savara Inc. SVRA|Equity per Share rigel.com (RIGL)|ANAB: Book Value per Share|Net Asset Value per Share Astria Therapeutics Inc ATXS|Book Value per Share ENGN (enGene Bio)|RAPT: Net Assets per Share|JBIO (aerovatetx.com) - Net Assets per Single Share|ACRS (aclaristx.com) - Accounting Value per Share|Net Assets per Single Share KYTX|Accounting Value per Share Tiziana Life Sciences Ltd. (TLSA)|Accounting Value per Share CABA|Book Value per Share VTYX (Ventyx Biosciences, Inc)|THTX - Net Assets per Single Share|avalotx.com - Equity per Share|ELDN (Eledon Pharmaceuticals, Inc.) - Net Assets per Single Share|Agenus, Inc. (AGEN) - Net Asset Value per Share|Climb Bio, Inc. (CLYM) - Accounting Value per Share|Zura Bio Ltd (ZURA) - Net Assets per Single Share|ATYR (aTyr Pharma, Inc.) - Book Value per Share|Book Value per Share ADAG|Net Assets per Single Share ImageneBio Inc IMA|Equity per Share shattucklabs.com STTK|Accounting Value per Share Equillium (EQ)|CNTB - Book Price of a Share|Accounting Value per Share Immunic Inc (IMUX)|ATRA - Accounting Value of a Share|inflarx.de - Book Value per Share|XFOR (X4 Pharmaceuticals Inc.) - Net Assets per Share|Net Assets per Single Share Adicet Bio Inc. (ACET)|Equity per Share Celularity Corp|Book Value per Share INMB (INmune Bio, Inc.)|Accounting Value per Share barinthusbio.com BRNS|Accounting Value per Share KZR|Net Assets per Share SAB Biotherapeutics Inc. SABS|Book Value per Share AKTX (Akari Therapeutics plc)|ENLV: Net Assets per Share|QTTB (q32bio.com) - Net Assets per Single Share|Accounting Value per Share geovax.com|Accounting Value per Share Edesa Biotech|Net Assets per Single Share iBio Inc (IBIO)|Accounting Value per Share Carisma Therapeutics|Book Price of a Share XTLB (XTL Bio)|Bolt Biotherapeutics, Inc. (BOLT) - Net Assets per Single Share|Share Book Value HCW Biologics, Inc. HCWB|Book Value per Share Aptevo (APVO)|AIM - Accounting Value of a Share|ADTX: Book Value per Share|GRI (GRI Bio Corporation) - Book Value per Share|XRTX - Net Assets per Single Share|Accounting Value of a Share HIND|Net Assets per Single Share REVB (Revelation Biosciences, Inc.)|Accounting Value per Share Indaptus Therapeutics Inc (INDP)|Book Value per Share SCNI (Scinai)|CALI - Book Value per Share|Accounting Value per Share Affimed Therapeutics (AFMD)|ALLK - Accounting Value of a Share|hookipapharma.com - Book Value per Share|IGMS (IGM Biosciences) - Net Assets per Share|Net Assets per Single Share ITOS|Accounting Value per Share OCEA|Net Assets per Single Share TCBP (TC Biopharm)|Accounting Value per Share thirdharmonicbio.com THRD